Clinical Trial Update: Study of 18F-Fluoro-PEG6-IPQA [Phase 1]

View source ↗

Summary

The document reports completion of a Phase 1 clinical trial evaluating the radiotracer 18F-Fluoro-PEG6-IPQA in lung cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 18F-Fluoro-PEG6-IPQA (18F-Fluoro-PEG6-IPQA)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED